Quince Therapeutics, Inc. (QNCX): PRE 14A filed Jul 31, 2026

Form type

PRE 14A

Filing date

Jul 31, 2026

Accession number

0001193125-26-328777

Filer

Quince Therapeutics, Inc. (CIK 1662774)